Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Neoplasms
Location: Lakewood CO, Sun City AZ, Austin TX, San Antonio TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06919965
Phase3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Aurora CO, Albuquerque NM, El Paso TX, Des Moines IA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Lakewood CO, Lone Tree CO, Wichita KS, Omaha NE,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Study of WAL0921 in Patients With Glomerular Kidney Diseases
for
Diabetic Nephropathies,
Location: Denver CO, Dakota Dunes SD, San Antonio TX,
Sponsor: Walden Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06466135
Phase2, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Aurora CO, Albuquerque NM, Sandy City UT, Ogden UT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07282600
Phase3, Recruiting
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Denver CO, Dallas TX, San Antonio TX, Nashville TN,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07372625
Phase1, Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Aurora CO, Overland Park KS, Kansas City KS, Phoenix AZ,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
A Study of BLB-201 RSV Vaccine in Infants and Children
for
Respiratory Syncytial Virus Infections
Location: Aurora CO, Grand Island NE, Newton KS, Lincoln NE,
Sponsor: Blue Lake Biotechnology Inc.
Sex: All
Age: 0 - 5
Code: NCT05655182
Phase1, Phase2, Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer